Dramatic Improvement of Antitranscription Intermediary Factor-1-γ/α Antibody-Positive Dermatomyositis After Stereotactic Body Radiation Therapy to Presumed Lung Primary: A Case Report

Pract Radiat Oncol. 2020 Nov-Dec;10(6):e551-e556. doi: 10.1016/j.prro.2020.06.008. Epub 2020 Jul 2.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Dermatomyositis*
  • Humans
  • Lung
  • Nuclear Proteins
  • Radiosurgery* / adverse effects
  • Transcription Factors

Substances

  • Nuclear Proteins
  • Transcription Factors
  • transcriptional intermediary factor 1